Login
Navigate Fool.com
Will AMGN beat
the market?

Amgen, Inc.

NASDAQ: AMGN

Community Rating: 4 Stars: Favorite

119.30 2.28 (1.95%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $117.24
Previous Close $117.02
Daily Range $117.05 - $119.71
52-Week Range $94.15 - $128.96
Market Cap $90.1B
P/E Ratio 17.62
Dividend (Yield) $2.44 (2.1%)
Ex-Dividend Date
Dividend Pay Date
05/13/14
06/06/14
Volume 4,278,206
Average Daily Volume 3,865,297
Current FY EPS $8.10

How do you think AMGN
will perform against the market?

Top AMGN Bull/Bear Pitches

 

FreeMortal (< 20)
Submitted December 23, 2009

Steadily growing earnings. Excellent margins and ROE. PE is fair, but it looks like this will drop; not because the price will drop, but because the earnings are poised to rise.

0 Replies Reply Report this Post
 

Jorgedig (17.04)
Submitted December 1, 2007

I sold my Amgen just before the new, strict Medicare guidelines came through on the use of Aranesp to treat chemotherapy-induced anemia. <br /><br /> <br /><br />I work in a cancer clinic, and we are … More

1 Replies Reply Report this Post

News & Commentary Rss Feed

New Drugs Help Drive Amgen's Operating Income Up 18% in Q1

Osteoporosis and oncology drugs push Amgen's revenue higher as the company sticks to its previously-issued 2014 outlook.

An Earnings Tale of Two Biotechs – Gilead vs. Amgen

After-Hours Earnings Report for April 22, 2014 : T, GILD, AMGN, CNI, YUM, DFS, ILMN, ISRG, VMW, FTI

After-Hours Earnings Report for April 22, 2014 : T, GILD, AMGN, CNI, YUM, DFS, ILMN, ISRG, VMW, FTI, JNPR, BCR

Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene

Stocks: Waiting for big tech earnings

Premarkets: Waiting for big tech earnings

McDonald’s, Gilead, Yum, AT&T are stocks to watch

What to Watch for in Biotech Earnings This Week

Several top biotechs will report earnings this week. Will they reignite the biotech rally or drive share prices even lower?

Week Ahead Market Report: April 21, 2014

4 Reasons You Should Watch This Under-the-Radar Stock on Your Watchlist

Little known NPS Pharmaceuticals has fallen hard of late, along with other biotechs. Yet there are four compelling reasons why you should keep tabs on this stock.

Earnings Primer: What's on Deck for Amgen Inc. and Biogen Idec Inc.

Here's what you need to know about Amgen (AMGN) and Biogen's (BIIB) upcoming first quarter earnings report.

See More AMGN News...

Sector

Healthcare

Industry

Drugs

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks